The store will not work correctly when cookies are disabled.
N-(((1r,4r)-4-aminocyclohexyl)methyl)-3-ethyl-N-methyl-[1,2,4]triazolo[4,3-b]pyridazin-6-amine
ID: ALA4877326
PubChem CID: 164626006
Max Phase: Preclinical
Molecular Formula: C15H24N6
Molecular Weight: 288.40
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCc1nnc2ccc(N(C)C[C@H]3CC[C@H](N)CC3)nn12
Standard InChI: InChI=1S/C15H24N6/c1-3-13-17-18-14-8-9-15(19-21(13)14)20(2)10-11-4-6-12(16)7-5-11/h8-9,11-12H,3-7,10,16H2,1-2H3/t11-,12-
Standard InChI Key: BRYGXEZJBKZFRT-HAQNSBGRSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
25.5081 -7.0416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5081 -7.8666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9321 -7.0416 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.2201 -6.6249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9321 -7.8666 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.2259 -8.2768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3977 -9.0752 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.2102 -9.1586 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.5404 -8.4115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3469 -8.2379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2201 -5.7999 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.9346 -5.3874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5056 -5.3874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5056 -4.5624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9005 -8.8496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2268 -4.1505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2288 -3.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5161 -2.9128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7999 -3.3240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7962 -4.1517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5193 -2.0878 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 4 1 0
2 6 1 0
5 3 1 0
3 4 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
9 10 1 0
4 11 1 0
11 12 1 0
11 13 1 0
14 13 1 1
10 15 1 0
14 16 1 0
14 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
18 21 1 6
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 288.40 | Molecular Weight (Monoisotopic): 288.2062 | AlogP: 1.64 | #Rotatable Bonds: 4 |
Polar Surface Area: 72.34 | Molecular Species: BASE | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.45 | CX LogP: 1.84 | CX LogD: -0.90 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.93 | Np Likeness Score: -2.19 |
References
1. Ratnayake AS, Flanagan ME, Foley TL, Hultgren SL, Bellenger J, Montgomery JI, Lall MS, Liu B, Ryder T, Kölmel DK, Shavnya A, Feng X, Lefker B, Byrnes LJ, Sahasrabudhe PV, Farley KA, Chen S, Wan J.. (2021) Toward the assembly and characterization of an encoded library hit confirmation platform: Bead-Assisted Ligand Isolation Mass Spectrometry (BALI-MS)., 41 [PMID:34000509] [10.1016/j.bmc.2021.116205] |